Bipolar Disorder Treatment Market To Surpass US$ 10,925.5 Million By 2027

1. BIPOLAR DISORDERS TREATMENT MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Bipolar Disorder Treatment Market - Overview Global Bipolar Disorder Treatment Market, By Drug Class (Antipsychotics, Antidepressants, Mood Stabilizers, and Anti-anxiety Drugs and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 7,288.3 million in 2019 and is expected to exhibit a CAGR of 5.2% over the forecast period (2019-2027), as highlighted in a new report published by Coherent Market Insights. Governments and healthcare organizations are supporting various clinical developmental stage companies and research organizations to develop novel drugs for the treatment of bipolar disorder, which is likely to drive the market growth over the forecast period. For instance, in January 2018, European Union’s Horizon 2020 Research and Innovation program awarded grant of US$ 8.8 million to R-Link, a cohort study for lithium initiation. The R-Link study has been initiated by researchers at Centre for Affective Disorders, Department of Psychological Medicine at the Institute of Psychiatry, Psychology & Neuroscience, King’s College London. Moreover, in June 2017, the Iowa Neuroscience Institute announced that it will grant fund of US$ 150,000 annually for five years to psychiatry research center (Department of Psychiatry in University of Iowa), in order to create a Bipolar Disorder Research Program of Excellence. Browse Research Reports: https://www.coherentmarketinsights.com/market-insight/bipolar- disorders-treatment-market-2605 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION Browse 27 Market Data Tables and 26 Figures spread through 201 Pages and in-depth TOC on “Bipolar Disorder Treatment Market”- Global Forecast to 2027, by Drug Class (Antipsychotics, Antidepressants, Mood Stabilizers, and Anti-anxiety Drugs and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa). Major players operating in the bipolar disorder treatment market are collaborating and partnering to focus on various operations ranging from research and development, manufacturing, sales and distribution, and others of bipolar disorder drugs, which is expected to boost the market growth over the forecast period. For instance, in February 2016, Sound Pharmaceuticals (SPI) announced collaboration with University of Oxford, in order to develop novel treatment for bipolar disorder. Under this collaboration agreement, in November 2017, both the companies collaboratively initiated the Phase II clinical trial for SPI-1005 for the treatment of patients with bipolar disorder. SPI-1005 is an oral drug containing ebselen, which mimics and induces the activity of Glutathione Peroxidase (GPx) in the inner ear and brain. The study was completed in July 2019. The global bipolar disorder treatment market is expected to exhibit a CAGR of 5.2% over the forecast period, owing to increasing product launches and approvals, and high prevalence of bipolar disorder. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/2605 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION Among drug class, antipsychotics segment held the largest market share in 2018, owing to increased prevalence of bipolar disorder. According to the National Alliance on Mental Illness Factsheet, September 2019, the annual prevalence of bipolar disorder in the U.S. was estimated at around 7 million. Among distribution channel, retail pharmacies segment held the largest market share in 2018, owing to patients’ preference to buy products through retail pharmacies and increasing number of retail or independent pharmacies. According to PLOS Journal, August 2017 findings, the number of independent pharmacies in the U.S. exhibited 3.8% growth from 22,737 (2007) to 23,596 (2015). Companies operating in the global bipolar disorder treatment market include Takeda Pharmaceutical Company Limited, Pfizer, Inc., Allergan plc, Otsuka Holdings Co. Ltd., Johnson & Johnson, Eli Lilly and Company, GlaxoSmithKline plc, AstraZeneca Plc, Novartis International AG, AbbVie Inc., H. Lundbeck A/S, Minerva Neurosciences, Sumitomo Dainippon Pharma Co., Ltd., Intra-Cellular Therapies Inc., Gedeon Richter Plc., and Indivior PLC. Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/2605 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved